The use of coal is responsible for (1)/(5) of global greenhouse gas (GHG) emissions. Substitution of coal with biomass fuels is one of a limited set of near-term options to significantly reduce these emissions. We investigate, on a life cycle basis, 100% wood pellet firing and cofiring with coal in two coal generating stations (GS) in Ontario, Canada. GHG and criteria air pollutant emissions are compared with current coal and hypothetical natural gas combined cycle (NGCC) facilities. 100% pellet utilization provides the greatest GHG benefit on a kilowatt-hour basis, reducing emissions by 91% and 78% relative to coal and NGCC systems, respectively. Compared to coal, using 100% pellets reduces NO(x) emissions by 40-47% and SO(x) emissions by 76-81%. At $160/metric ton of pellets and $7/GJ natural gas, either cofiring or NGCC provides the most cost-effective GHG mitigation ($70 and $47/metric ton of CO2 equivalent, respectively). The differences in coal price, electricity generation cost, and emissions at the two GS are responsible for the different options being preferred. A sensitivity analysis on fuel costs reveals considerable overlap in results for all options. A lower pellet price ($100/metric ton) results in a mitigation cost of $34/metric ton of CO2 equivalent for 10% cofiring at one of the GS. The study results suggest that biomass utilization in coal GS should be considered for its potential to cost-effectively mitigate GHGs from coal-based electricity in the near term.

No abstract

No abstract

Mouse sperm-egg binding requires a multiplicity of receptorligand interactions, including an oviduct-derived, high molecular weight, wheat germ agglutinin (WGA)-binding glycoprotein that associates with the egg coat at ovulation. Herein, we report the purification and identification of this sperm-binding ligand. WGA-binding, high molecular weight glycoproteins isolated from hormonally primed mouse oviduct lysates competitively inhibit sperm-egg binding in vitro. Within this heterogeneous glycoprotein preparation, a distinct 220 kDa protein selectively binds to sperm surfaces, and was identified by sequence analysis as oviduct-specific glycoprotein (OGP). The sperm-binding activity of OGP was confirmed by the loss of sperm-binding following immunodepletion of OGP from oviduct lysates, and by the ability of both immunoprecipitated OGP and natively purified OGP to competitively inhibit spermegg binding. As expected, OGP is expressed by the secretory cells of the fimbriae and infundibulum; however, in contrast to previous reports, OGP is also associated with both the zona pellucida and the perivitelline space of mouse oocytes. Western blot analysis and lectin affinity chromatography demonstrate that whereas the bulk of OGP remains soluble in the ampullar fluid, distinct glycoforms associate with the cumulus matrix, zona pellucida and perivitelline space. The sperm-binding activity of OGP is carbohydrate-dependent and restricted to a relatively minor peanut agglutinin (PNA)-binding glycoform that preferentially associates with the sperm surface, zona pellucida and perivitelline space, relative to other more abundant glycoforms. Finally, pretreatment of two-cell embryos, which do not normally bind sperm, with PNA-binding OGP stimulates sperm binding.

Many new chemicals come into use each year, and the need for rapid and cost-effective methods for testing developmental toxicity is apparent. Establishing reliable in vitro techniques is important to a tier approach to testing for developmental toxicity. The fetal mouse salivary gland was selected as a possible test system because several interacting developmental processes occur in gland growth, and development is quantifiable by counting lobes. For each chemical tested, 20 glands from 13-day embryos were treated in a control media and in three concentrations of the test chemicals. The number of lobes present after 48 hours is dependent on the number of lobes at explantation. Glands with different numbers of lobes at explantation were compared by dividing the number of lobes present after 48 hours by the number present at explantation to determine a growth ratio. Mean growth ratios were used to construct dose-response curves, and from these curves the concentration that reduced growth by 50% (TP50) was determined. Comparisons with in vivo data were made by calculating three ratios; the TP50 was divided into the lowest teratogenic dose, the lowest maternal toxic dose, and the dose that was lethal to 50%. Four in vivo teratogens, 6-aminonicotinamide, cytochalasin B, hydroxyurea, and 3-acetylpyridine, all had ratios much higher than 1, indicating a very sensitive response by the glands. One in vivo teratogen, dexamethasone, had much lower ratios, indicating less sensitivity. Acetaminophen, a nonteratogen in vivo, actually stimulated growth of the glands at 10(-5) M and had very low ratios indicating a minimal response by the glands.